.... moving towards a tobacco free india

TFI Login

Username or email

Password

Remember me

No account yet? Register

Indian oncology market likely to triple in 4 years

Mumbai: April 1, 2010:- The oncology market in India is expected to touch nearly Rs 3,309 crore by 2014. According to a recent Frost & Sullivan report, the cancer market is expected to grow at a compounded annual growth rate (CAGR) of 21% from 2008 to 2014. The growth will be driven by the introduction of new treatments, increasing number of patients on chemotherapy, and improved access to modern cancer therapies. The Indian oncology market stood at Rs 1,065 crore in 2008.

Deaths from lung cancer, breast cancer, ovarian cancer and pancreatic cancer are rising in India. Cancer accounts for 8% of the main causes of deaths in India.

Increased rates of incidence of various cancer types prevailing in India has created interest among various companies like BMS, Pfizer, Roche, Sanofi-Aventis, GSK, SP Corporation, Fresenius Kabi, Natco Pharma, Sun Pharma, Dr Reddy's and Biocon to focus in the oncology segment. More than 30 companies in India market drugs for cancer treatment.

Please Login to read the full article

< Prev		Next >

Discuss this item on the forums. (0 posts)

Tobacco Facts

Because there is a lag of several years between when people start using tobacco and when their health suffers, the epidemic of disease and death (as it appears today) has just begun in this world. Millions are going to die due to tobacco.

100 million deaths were caused by tobacco in the 20th century. If current trends continue, there will be up to one billion deaths in the 21st century.
Unchecked, tobacco-related deaths will increase to more than eight million a year by 2030, and 80% of those deaths will occur in the developing world.